US$9 Billion Valuation Is Rarefied Air
Samsung's proposed ~US$9 billion valuation for Samsung BioLogics would out the latter in a very select company: a US$9 billion market cap for a...
247 Views
Update on Samsung Heavy's Rights Offering: Smaller Size than Expected Creates Positive Sentiment
Samsung Heavy Industries is said to have decided to keep the rights offering to less than ₩1tril (US$908mil), and more importantly, Samsung Heavy...
281 Views
Start of One-Shot Act - The Good, Bad, and the Ugly
The "One-Shot Act" (also called The Special Act on the Corporate Revitalization) effectively started in Korea on 16 August when Hanwha Chemical...
1.1k Views
Key Factors of Samsung Heavy's KRW1tril Capital Increase
Samsung Heavy is expected to raise its capital by KRW1tril (at least).* Last month (June), Samsung Heavy’s board voted to hold an ad hoc...
221 Views
Close Out the Shorts on Korean Construction Stocks?
The four major construction stocks in Korea Hyundai Engineering & Const, Hyundai Development Co Engg & Cnstn, Gs Engineering &...
274 Views